PT  - JOURNAL ARTICLE
AU  - McBane, Robert D
AU  - Murphree, Dennis H.
AU  - Liedl, David
AU  - Lopez-Jimenez, Francisco
AU  - Attia, Itzhak Zachi
AU  - Arruda-Olson, Adelaide M.
AU  - Scott, Christopher G.
AU  - Prodduturi, Naresh
AU  - Nowakowski, Steve E.
AU  - Rooke, Thom W.
AU  - Casanegra, Ana I.
AU  - Wysokinski, Waldemar E.
AU  - Houghton, Damon E.
AU  - Bjarnason, Haraldur
AU  - Wennberg, Paul W.
TI  - Artificial intelligence of arterial Doppler waveforms to predict major adverse outcomes among patients evaluated for peripheral artery disease
AID  - 10.1101/2023.07.21.23293024
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.07.21.23293024
4099  - http://medrxiv.org/content/early/2023/07/24/2023.07.21.23293024.short
4100  - http://medrxiv.org/content/early/2023/07/24/2023.07.21.23293024.full
AB  - Background Patients with peripheral arterial disease (PAD) are at increased risk for major adverse cardiac (MACE), limb (MALE) events and all-cause mortality. Developing tools capable of identifying those patients with PAD at greatest risk for major adverse events is the first step for outcome prevention. This study aimed to determine whether computer assisted analysis of a resting Doppler waveform using deep neural networks can accurately identify PAD patients at greatest risk for adverse outcome events.Methods Consecutive patients (4/1/2015-12/31/2020) undergoing ankle brachial index (ABI) testing were included. Patients were randomly allocated to training, validation and testing subsets (60%/20%/20%). Deep neural networks were trained on resting posterior tibial arterial Doppler waveforms to predict MACE, MALE and all-cause mortality at 5 years. Patients were then analyzed in quartiles based on the distribution of each prediction score.Results Among 11,384 total patients, 10,437 patients met study inclusion criteria (mean age 65.8±14.8 years; 40.6% female). The test subset included 2,084 patients. During 5 years of follow up, there were 447 deaths, 585 MACE and 161 MALE events. After adjusting for age, sex, and Charlson index, deep neural network analysis of the posterior tibial artery waveform provided independent prediction of death (Hazard ratio 2.45 95% confidence interval 1.79-3.36), MACE (HR 1.98, 95%CI 1.50-2.62) and MALE (HR 11.65 95%CI 5.65-24.04) at 5 years with similar results at 1 year.Conclusion An artificial intelligence enabled analysis of a resting Doppler arterial waveform enables identification of major adverse outcomes including all-cause mortality, MACE and MALE among PAD patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Mayo Clinic IRBI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data will not be made available for public use at this time.